Global reach, higher impact. Enter your search terms www.jbiomed.com Submit search form . This journal ceased publication from November 2019. Journal of Biomedicine is a multidisciplinary journal publishing papers of high quality in the study of biology, biological processes and application in medicine.

Biomedical risk factors are bodily states that have an impact on a person’s risk of disease. This page focuses on 3 biomedical risk factors: blood pressure, blood lipids and blood glucose—elevated levels of which have been directly linked to specific health outcomes such as cardiovascular disease, including coronary heart disease and stroke, chronic kidney disease and diabetes.

According to the Journal Citation Reports, the journal has a 2019 impact factor of 4.545. References External links. Official website; This page was last Impact BioMedicines, Inc. 1 like. Biotechnology Company.

Biomedicines impact factor

BioMed Central will continue to About the Journal. "Novelty in Biomedicine (NBM)" is a quarterly publication of the Shahid Beheshti University of Medical Sciences. eISSN 2345-3907. IEEE Transactions on Information Technology in Biomedicine. The IEEE Transactions on Information Technology in Biomedicine publishes basic and applied Apr 3, 2021 About the Journal. Biomedicine (Print ISSN: 0970 2067), official publication of Indian Association of Biomedical Scientists (IABMS), published BioMedicine and Surgery provides rapid publication of articles in all areas of medical, surgical and public health sciences.

Impact Biomedicines, Inc. operates as a biotechnology company. The Company focuses on development of life-changing treatments for patients with myeloproliferative neoplasms and other cancers.

The two years line is equivalent to journal impact factor ™ (Thomson Reuters) metric. Biomedicines (ISSN 2227-9059) is an open access journal devoted to all aspects of research on human health and disease, the discovery and characterization of new therapeutic targets, therapeutic strategies, and research of naturally driven biomedicines, pharmaceuticals, and biopharmaceutical products.

IJBM publishes peer-reviewed articles on the topics of basic, applied, and translational research in biology and medicine. IJBM is indexed by the following

The Biomedicines Factor de Impacto measures the average number of citations received in a particular year (2020) by papers published in the Biomedicines during the two preceding years (2018-2019). Note that 2020 Journal Impact are reported in 2021; they cannot be calculated until all of the 2020 publications have been processed by the indexing agency. International Scientific Journal & Country Ranking. Only Open Access Journals Only SciELO Journals Only WoS Journals Journal impact search engine.

Impact Biomedicines, Inc. operates as a biotechnology company. The Company focuses on development of life-changing treatments for patients with myeloproliferative neoplasms and other cancers. The chart shows the evolution of the average number of times documents published in a journal in the past two, three and four years have been cited in the current year.
Heine atta troll

Information for. Authors · Editors IMPACT FACTOR 4.717 · Journals. Biomedicines. biomedicines-logo Biomedicines 2021, 9(4), 418; https://doi.org/10.3390/biomedicines9040418 ( registering Journal of Negative Results in Biomedicine (JNRBM) will cease to be published by BioMed Central as of 1stSeptember 2017.

Impact Factor: 0.324. Five Year Impact Biomedicine & Pharmacotherapy Impact Factor, IF, number of article, detailed information and journal factor.
Falköpings tidning digital

cc army depot
frisør engelska
spelstopp v86 onsdag
älvsbyns energi fjärrvärme
hm sverige
hur mycket kan man ta betalt för ett rum
bussförarutbildning sl

BioMed Research International is a peer-reviewed open access scientific journal covering all aspects of biomedical sciences.It was established in 2001 as the Journal of Biomedicine and Biotechnology with Abdelali Haoudi as first editor-in-chief (until 2008). The journal obtained its current title in 2013 and is published by Hindawi Publishing Corporation.

Note that 2020 Journal Impact are reported in 2021; they cannot be calculated until all of the 2020 publications have been processed by the indexing agency. Biomedicine & Pharmacotherapy Impact Factor, IF, number of article, detailed information and journal factor. ISSN: 0753-3322. The Biomedicines Fattore di Impatto measures the average number of citations received in a particular year (2020) by papers published in the Biomedicines during the two preceding years (2018-2019). Impact Factor: 2019: 3.697 The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

The impact factor (IF) 2018 of Biomedicine is 0.06, which is computed in 2019 as per it's

Companion journals for Biomedicines include: IJTM and BioMed. Impact Factor: 4.717 (2019) subject Imprint Information get_app Journal Flyer Open Access · The 2019-2020 Journal Impact IF of Biomedicines is 4.757 Biomedicines Key Factor Analysis · The 2018-2019 Journal Impact IF of Biomedicines is 3.684 Biomedicines Key Factor Analysis · The 2017-2018 Journal Impact IF of Biomedicines is 1.867 Biomedicines … 10 rows Biomedicines (ISSN 2227-9059) is an open access journal devoted to research of naturally driven biomedicines, pharmaceuticals, and biopharmaceutical products. The topics include natural bioactive molecules, biologics, biosimilar, vaccines, gene therapies, cell-based therapies, targeted specific antibodies, recombinant therapeutic proteins, 19 rows SciProfiles.

There are a few key factors that limit the pandemic's impact on the study Dina holds a M.Sc. in Biomedicine from Uppsala.